Developing Smart & Fitfor- Purpose ADC Development Strategies to Improve Safety & Efficacy

Time: 10:00 am
day: Track B - Pre-conf-AM


  • Understanding the importance of the target and the engineered antibody
  • Evaluating what payloads are better suited for low vs. high target expression?
  • Discussing whether on target toxicities can be minimized by intelligent engineering and combination approaches
  • Sharing translational approaches to maximize the value of clinical trials